Latest updates in Advanced Systemic Mastocytosis from EHA 2022 - European Medical Journal

Latest updates in Advanced Systemic Mastocytosis from EHA 2022

Hematology

This content was funded and sponsored by Blueprint Medicines GmbH

Targeting systemic mastocytosis

Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the  session on overcoming the challenges in diagnosis and management of advanced systemic Mastocytosis.

07.2022 INT-BP-MED-AVAASM-22046.1

Lessons learned in the diagnosis of Advanced SM

Update in Haematology session EHA 2022, Prof. Andreas Reiter and Prof. Karl Sotlar discuss the diagnostic challenges of Advanced SM in patients. This session also addresses the issue of disease awareness and how to improve the diagnosis of advanced systemic mastocytosis.

07.2022 INT-BP-MED-AVAASM-22047.1

Management of Advanced SM: The state-of-the-art in the precision medicine era

Update in Haematology session EHA 2022, Dr. Deepti Radia and Prof. Andreas Reiter present the current treatment landscape for patients with advanced systemic mastocytosis and also discuss the latest developments for patient management.

07.2022 INT-BP-MED-AVAASM-22048.1

Clinical Case presentation

Update in Haematology session EHA 2022, Dr. Deepti Radia and Dr Francesco Mannelli present two case studies of patients with advanced systemic mastocytosis and discuss their clinical management.

07.2022 INT-BP-MED-AVAASM-22049.1

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.